Eli Lilly and Co. is pursuing litigation against Teva Parenteral
Medicines, Inc. and APP Pharmaceuticals, LLC over the infringement
of the Alimta(R) compound patent in the U.S. District Court for…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.